]A cannabis-based drug which can be taken by multiple sclerosis (MS) sufferers has been approved for use in the UK.
Sativex will be marketed in the UK by its licensee Bayer, according to GW Pharmaceuticals. The firm told Reuters news agency that a 10 millilitre vial - enough to last a patient about 11 days - would cost the NHS £125.
Compounds taken from marijuana plants are used in the drug and research has shown that Sativex, which is sprayed under the tongue, cuts down spasticity in MS patients who do not respond to conventional treatment.
The NICE has still to rule on whether Sativex is cost-effective enough to be used by the NHS.
It was the first cannabis medicine in the world to gain regulatory backing five years ago when it was approved by Canadian authorities for neuropathic pain. Its entry into the UK - and possible other European countries as a result - will see it become available to a larger market.
View attachment 15201
21 June, 2010
Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.